Uveal melanoma dormancy: an acceptable clinical endpoint?

Abstract

Uveal melanoma is a rare but life-threatening malignancy. Over the past decades, the morbidity of uveal melanoma has been markedly reduced as a result of advances in the diagnostic ability to detect smaller tumors at an earlier stage. This has allowed for the use of more conservative treatments, avoiding enucleation. Mortality, however, has remained… (More)
DOI: 10.1097/CMR.0b013e328357bea8

Topics

Cite this paper

@article{Blanco2012UvealMD, title={Uveal melanoma dormancy: an acceptable clinical endpoint?}, author={Paula L Blanco and Li Anne Lim and Cristina Miyamoto and Miguel Noel Burnier}, journal={Melanoma research}, year={2012}, volume={22 5}, pages={334-40} }